STRONCON GmbH

Strategic Consulting for Oncology Drug Development

​

The company operates globally and works with pharma and biotech companies, investors, and boards.

My scope spans the entire continuum of oncology drug development and with a focus on strategic clinical and regulatory decision points.

​

At the intersection of scientific complexity, regulatory risk, and long-term value creation, I support companies and boards through strategic advisory roles, interim C-level leadership, and independent board or advisory positions.